DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Chen et al. compared skeletal muscle tissue from control donors and patients with dystrophin or alpha-sarcoglycan deficiencies, providing a description of common and unique variations in gene expression for these two forms of dystrophinopathy [71].